Elevance Health Inc. ELV NYSE

Elevance Health Inc. (ELV) has shown moderate revenue growth over the past 3 years, expanding from $156.6B to $199.1B (average +8.4%/yr). Net income reached $5.7B, reflecting earnings decline at -1.3%/yr on average. The net profit margin is 2.8%, which is thin. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 25.6% (low), with a +0.1pp trend over the period. With a $69B market cap and MOAT composite score of 63/100, the company has a moderate competitive position.

Criteria proven by this page:

• GROWTH (40/100, Partial) — growth is present but not consistently above 5% across both metrics
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 28-year history, the company was profitable in 28 of 28 years — a perfect long-term track record
• INCOME (30/100, Partial) — the company is profitable but margin is below 15%
• MOAT (63/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 62/100 with 3/7 criteria passed.